Clinical translation of graphene-based medical technology

Abstract

Many promising technologies created in academic laboratories struggle to transition to industry because of rapid shifts in research direction, funding constraints and complex challenges, hindering their full development. Here, the founders of ‘INBRAIN Neuroelectronics’, a start-up working on graphene-based high-precision neural interface systems, describe how a different outcome is possible.